Prulifloxacin

It is used to treat the following infections caused by Staphylococcus aureus, gonococci, pneumococci, enterococci, Moraxella, Escherichia coli, Shigella, Salmonella (except typhoid and paratyphoid bacteria), Citrobacter, Klebsiella, enterobacteria, Serratia, Proteus, cholera, influenza, Pseudomonas aeruginosa, and Streptococcus aureus that are sensitive to prulifloxacin: 1. Superficial skin infections (acute superficial folliculitis, infectious pus crust), deep skin infections (cellulitis, erysipelas, furunculosis, etc.) 1. Acute upper respiratory tract infection (pharyngitis, tonsillitis, acute bronchitis, etc.), secondary infection of chronic respiratory diseases (chronic bronchitis, diffuse bronchiolitis, bronchiectasis, emphysema, pulmonary fibrosis, bronchial asthma, etc.) and pneumonia. 2. Chronic pyoderma (infected sebaceous gland cyst, suppurative hidradenitis, subcutaneous abscess); 3. Acute upper respiratory tract infection (pharyngitis, tonsillitis, acute bronchitis, etc.), secondary infection of chronic respiratory diseases (chronic bronchitis, diffuse bronchiolitis, bronchiectasis, emphysema, pulmonary fibrosis, bronchial asthma, etc.) and pneumonia. 4. Cystitis, pyelonephritis, prostatitis; 5. Cholecystitis, cholangitis; 6. Infectious enteritis, bacillary dysentery, typhoid fever, cholera; 7. Intrauterine infection, adnexitis; 8. Blepharitis, sty; 9. Otitis media, sinusitis.

People who are allergic to this product are prohibited from using it, and those with allergic constitutions should use it with caution.

API

Shandong Luoxin Pharmaceutical Group HENGXIN Pharmaceutical Co., Ltd.

• Founded in:

  2011-04-11

• Address:

  West side of Yanbin Road, Feixian Economic Development Zone

• Tax NO.:

  913713255728813685

• Registered Funds:

  50 million yuan

• Email:

  Log in to view